BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 9287939)

  • 1. Minimum inhibitory concentration (MIC) of some antibiotics against Vibrio cholerae O139 isolates from Pondicherry.
    Vijayalakshmi N; Rao RS; Badrinath S
    Epidemiol Infect; 1997 Aug; 119(1):25-8. PubMed ID: 9287939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expanding multiple antibiotic resistance among clinical strains of Vibrio cholerae isolated from 1992-7 in Calcutta, India.
    Garg P; Chakraborty S; Basu I; Datta S; Rajendran K; Bhattacharya T; Yamasaki S; Bhattacharya SK; Takeda Y; Nair GB; Ramamurthy T
    Epidemiol Infect; 2000 Jun; 124(3):393-9. PubMed ID: 10982062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emergence of tetracycline resistance due to a multiple drug resistance plasmid in Vibrio cholerae O139.
    Yamamoto T; Nair GB; Takeda Y
    FEMS Immunol Med Microbiol; 1995 Apr; 11(2):131-6. PubMed ID: 7640673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quinolone susceptibility of Vibrio cholerae O1 & O139 isolates from Vellore.
    Jesudason MV; Balaji V; Thomson CJ
    Indian J Med Res; 2002 Sep; 116():96-8. PubMed ID: 12619447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistance of Vibrio cholerae 01 to nalidixic acid.
    Jesudason MV; Saaya R
    Indian J Med Res; 1997 Apr; 105():153-4. PubMed ID: 9145595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new type of conjugative transposon encodes resistance to sulfamethoxazole, trimethoprim, and streptomycin in Vibrio cholerae O139.
    Waldor MK; Tschäpe H; Mekalanos JJ
    J Bacteriol; 1996 Jul; 178(14):4157-65. PubMed ID: 8763944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emergence of furazolidone and cotrimoxazole resistant Vibrio cholerae 01 in eastern India.
    Niyogi SK; Sengupta PG; Bhattacharya SK; Garg S; Mukhapadhayay AK; Nair GB
    J Infect; 1995 May; 30(3):265-6. PubMed ID: 7673756
    [No Abstract]   [Full Text] [Related]  

  • 8. In vitro susceptibility of pathogenic Vibrio species to norfloxacin and six other antimicrobial agents.
    Morris JG; Tenney JH; Drusano GL
    Antimicrob Agents Chemother; 1985 Sep; 28(3):442-5. PubMed ID: 4073866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trend of antibiotic resistance of Vibrio cholerae strains from East Delhi.
    Das S; Saha R; Kaur IR
    Indian J Med Res; 2008 May; 127(5):478-82. PubMed ID: 18653912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of a clinical Vibrio cholerae O139 isolate from Mexico.
    Parveen S; Farrah SR; Gonzalez-Bonilla C; Zamudio AV; Tamplin ML
    Can J Microbiol; 2003 Jan; 49(1):65-70. PubMed ID: 12674350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Global status of antimicrobial resistance among environmental isolates of Vibrio cholerae O1/O139: a systematic review and meta-analysis.
    Yuan XH; Li YM; Vaziri AZ; Kaviar VH; Jin Y; Jin Y; Maleki A; Omidi N; Kouhsari E
    Antimicrob Resist Infect Control; 2022 Apr; 11(1):62. PubMed ID: 35468830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increasing antimicrobial resistance of Vibrio cholerae OI biotype E1 tor strains isolated in a tertiary-care centre in India.
    Mandal J; Dinoop KP; Parija SC
    J Health Popul Nutr; 2012 Mar; 30(1):12-6. PubMed ID: 22524114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Activity of 22 antibacterials against O1 and O139 serogroup Vibrio cholerae strains isolated from humans within 1927-2005 in various regions of the world].
    Ryzhko IV; Dudina NA; Lomov IuM; Shut'ko AG; Tsuraeva RI; Anisimov BI
    Antibiot Khimioter; 2005; 50(8-9):38-42. PubMed ID: 17016910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Susceptibility of Vibrio cholerae El-Tor strains to various antibiotics].
    Willke A; Arman D; Tolunay C
    Mikrobiyol Bul; 1988 Apr; 22(2):101-4. PubMed ID: 3273600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diversity of Vibrio cholerae strains isolated in Delhi, India, during 1992-2000.
    Das S; Gupta S
    J Health Popul Nutr; 2005 Mar; 23(1):44-51. PubMed ID: 15884751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial resistance among clinical
    Wu Q; Vaziri AZ; Omidi N; Hassan Kaviar V; Maleki A; Khadivar P; Kouhsari E
    Pathog Glob Health; 2023 May; 117(3):235-244. PubMed ID: 35983997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergence of Vibrio cholerae O1 Biotype El Tor serotype Inaba in north India.
    Taneja N; Biswal M; Tarai B; Sharma M
    Jpn J Infect Dis; 2005 Aug; 58(4):238-40. PubMed ID: 16116259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Globally Vibrio cholera antibiotics resistance to RNA and DNA effective antibiotics: A systematic review and meta-analysis.
    Rostami A; Zadeh FA; Ebrahimzadeh F; Jafari-Sales A; Gholami S
    Microb Pathog; 2022 Nov; 172():105514. PubMed ID: 35537594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology & antibiograms of Vibrio cholerae isolates from a tertiary care hospital in Chandigarh, north India.
    Chander J; Kaistha N; Gupta V; Mehta M; Singla N; Deep A; Sarkar BL
    Indian J Med Res; 2009 May; 129(5):613-7. PubMed ID: 19675394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Vibrio cholerae strains resistant to vibriostatic factor 0/129 isolated from a patient with cholera in Poland].
    Stypułkowska-Misiurewicz H; Gardocka H; Sieczka Z
    Med Dosw Mikrobiol; 1994; 46(4):313-21. PubMed ID: 7603133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.